• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一项关于婴儿血管瘤的前瞻性研究,重点关注发病率和危险因素。

A prospective study of infantile hemangiomas with a focus on incidence and risk factors.

作者信息

Dickison Philippa, Christou Elizabeth, Wargon Orli

机构信息

Department of Dermatology, Sydney Children's Hospital, Randwick, Australia.

University of New South Wales, Sydney, Australia.

出版信息

Pediatr Dermatol. 2011 Nov-Dec;28(6):663-669. doi: 10.1111/j.1525-1470.2011.01568.x. Epub 2011 Oct 13.

DOI:10.1111/j.1525-1470.2011.01568.x
PMID:21995808
Abstract

Infantile hemangiomas (IHs) are the most common tumor of infancy and have been estimated to occur in 4% of infants. Only two previous incidence studies of IH in a healthy population have been published, and both of these were performed in the first week of life. The objective was to identify the incidence of IH in an Australian neonatal population and characterize the risk factors. All women who presented to the postnatal ward in a 200-bed maternity hospital were asked to complete a questionnaire. Details of maternal history and birth details were recorded. Two follow-up emails 3 and 6 weeks after discharge were sent to all mothers who consented, asking if their baby had developed an IH. Babies reported to have an IH were seen in clinic to confirm the diagnosis. Details were collected from 1,034 mothers of 1,065 babies; 28 (2.6%) of the infants developed IH. Babies that developed IH were more likely to be female (p < 0.001), have a low birth weight (p = 0.020), be born at a gestational age of <37 weeks (p = 0.005), and be conceived through in vitro fertilization (IVF) (p = 0.001) than those who did not. The incidence of IH at 6 weeks of life was 2.6%.

摘要

婴儿血管瘤(IHs)是婴儿期最常见的肿瘤,据估计,4%的婴儿会发生该疾病。此前仅有两项关于健康人群中婴儿血管瘤发病率的研究发表,且这两项研究均在出生后第一周进行。本研究的目的是确定澳大利亚新生儿群体中婴儿血管瘤的发病率,并对风险因素进行特征分析。所有入住一家拥有200张床位的妇产医院产后病房的女性均被要求填写一份问卷。记录产妇病史和出生详情。在出院后3周和6周向所有同意参与的母亲发送两封随访电子邮件,询问其婴儿是否患上婴儿血管瘤。报告患有婴儿血管瘤的婴儿会被安排到门诊进行诊断确认。收集了1065名婴儿的1034名母亲的详细信息;其中28名(2.6%)婴儿患上了婴儿血管瘤。与未患婴儿血管瘤的婴儿相比,患上该病的婴儿更有可能为女性(p < 0.001)、出生体重低(p = 0.020)、孕周<37周(p = 0.005)以及通过体外受精(IVF)受孕(p = 0.001)。出生6周时婴儿血管瘤的发病率为2.6%。

相似文献

1
A prospective study of infantile hemangiomas with a focus on incidence and risk factors.一项关于婴儿血管瘤的前瞻性研究,重点关注发病率和危险因素。
Pediatr Dermatol. 2011 Nov-Dec;28(6):663-669. doi: 10.1111/j.1525-1470.2011.01568.x. Epub 2011 Oct 13.
2
Increasing incidence of infantile hemangiomas (IH) over the past 35 years: Correlation with decreasing gestational age at birth and birth weight.过去35年中婴儿血管瘤(IH)发病率的上升:与出生时孕周和出生体重下降的相关性。
J Am Acad Dermatol. 2016 Jan;74(1):120-6. doi: 10.1016/j.jaad.2015.08.024. Epub 2015 Oct 19.
3
Maternal and Perinatal Factors of Importance for Occurrence and Severity of Infantile Haemangioma.对婴儿血管瘤发生及严重程度具有重要意义的母体和围产期因素。
Acta Derm Venereol. 2015 Jul;95(6):696-9. doi: 10.2340/00015555-2042.
4
Anatomical patterns of infantile hemangioma (IH) of the extremities (IHE).四肢婴儿血管瘤(IHE)的解剖模式。
J Am Acad Dermatol. 2016 Sep;75(3):556-563. doi: 10.1016/j.jaad.2016.03.029. Epub 2016 Apr 22.
5
Update on infantile hemangiomas.婴幼儿血管瘤最新进展。
Semin Perinatol. 2013 Feb;37(1):49-58. doi: 10.1053/j.semperi.2012.11.003.
6
Inheritance Patterns of Infantile Hemangioma.婴儿血管瘤的遗传模式。
Pediatrics. 2016 Nov;138(5). doi: 10.1542/peds.2016-1623. Epub 2016 Oct 12.
7
Outpatient use of oral propranolol and topical timolol for infantile hemangiomas: survey results and comparison with propranolol consensus statement guidelines.口服普萘洛尔和局部用噻吗洛尔治疗婴儿血管瘤的门诊应用:调查结果及与普萘洛尔共识声明指南的比较
Pediatr Dermatol. 2015 Mar-Apr;32(2):171-9. doi: 10.1111/pde.12435. Epub 2014 Dec 29.
8
Hemangiomas and the eye.血管瘤与眼睛。
Clin Dermatol. 2015 Mar-Apr;33(2):170-82. doi: 10.1016/j.clindermatol.2014.10.009.
9
Oral atenolol therapy for proliferating infantile hemangioma: A prospective study.口服阿替洛尔治疗增殖期婴儿血管瘤:一项前瞻性研究。
Medicine (Baltimore). 2016 Jun;95(24):e3908. doi: 10.1097/MD.0000000000003908.
10
[Rare presentations of infantile hemangiomas: 4 cases].[婴儿血管瘤的罕见表现:4例]
Ann Dermatol Venereol. 2018 Dec;145(12):749-755. doi: 10.1016/j.annder.2018.07.026. Epub 2018 Nov 9.

引用本文的文献

1
Infantile Hemangioma: Risk Factors and Management in a Preterm Patient-A Case Report.婴儿血管瘤:一名早产儿患者的危险因素及管理——病例报告
Reports (MDPI). 2024 Jan 1;7(1):3. doi: 10.3390/reports7010003.
2
Nanotechnology in Infantile Hemangioma Management.纳米技术在婴幼儿血管瘤治疗中的应用
J Pediatr Pharmacol Ther. 2025 Feb;30(1):27-46. doi: 10.5863/1551-6776-30.1.27. Epub 2025 Feb 10.
3
Optimizing Propranolol Therapy for Infantile Hemangiomas: The Role of the Multidisciplinary Team.优化普萘洛尔治疗婴幼儿血管瘤:多学科团队的作用。
Cureus. 2024 Dec 16;16(12):e75806. doi: 10.7759/cureus.75806. eCollection 2024 Dec.
4
Adverse pregnancy outcomes and multiple cancers risk in both mother and offspring: an umbrella review of systematic reviews with meta-analyses of observational studies.不良妊娠结局和母婴多种癌症风险:对观察性研究系统评价和荟萃分析的伞式综述。
BMC Med. 2024 Oct 11;22(1):454. doi: 10.1186/s12916-024-03680-w.
5
Identification of Potential Therapeutics for Infantile Hemangioma via in silico Investigation and in vitro Validation.通过计算机筛选和体外验证鉴定婴儿血管瘤的潜在治疗药物。
Drug Des Devel Ther. 2024 Sep 12;18:4065-4088. doi: 10.2147/DDDT.S460575. eCollection 2024.
6
Timing and Efficacy Evaluation of 755-nm Long Pulse Alexandrite Laser and 2% Carteolol Hydrochloride Eye Drops Co-Treatment for Thicker Superficial Infantile Hemangioma.755纳米长脉冲翠绿宝石激光联合2%盐酸卡替洛尔滴眼液治疗较厚浅表型婴幼儿血管瘤的时机及疗效评估
Clin Cosmet Investig Dermatol. 2024 Sep 5;17:2009-2019. doi: 10.2147/CCID.S483141. eCollection 2024.
7
Advances in Mass Spectrometry of Gangliosides Expressed in Brain Cancers.脑癌中表达的神经节苷脂的质谱分析进展
Int J Mol Sci. 2024 Jan 22;25(2):1335. doi: 10.3390/ijms25021335.
8
Mental Health of School-Aged Children Treated with Propranolol or Atenolol for Infantile Hemangioma and Their Parents.婴幼儿血管瘤患儿接受普萘洛尔或阿替洛尔治疗后的学龄期儿童及其家长的心理健康状况。
Dermatology. 2024;240(2):216-225. doi: 10.1159/000536144. Epub 2024 Jan 16.
9
Recent updates in laryngeal hemangioma management: a scoping review.喉部血管瘤治疗的最新进展:范围综述。
Eur Arch Otorhinolaryngol. 2024 May;281(5):2211-2222. doi: 10.1007/s00405-023-08378-y. Epub 2023 Dec 29.
10
Overview of the Head and Neck Hemangiomas: a 5-year Retrospective Study.头颈部血管瘤概述:一项5年回顾性研究
Mater Sociomed. 2023 Sep;35(3):244-247. doi: 10.5455/msm.2023.35.244-247.